Search

everythinglearnresearchcommunity

for

Search:↓

Certain factors like being female, having high cholesterol, using Medicaid, and previous non-biologic treatments increase the risk of multiple biologic failures in psoriasis patients.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

The rash resolved after stopping ponatinib.

The name Janus is fitting for JAK inhibitors as they revolutionize dermatology treatments.

The patch effectively promotes hair growth for alopecia areata without pain.

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

The care model improved timely diagnosis and treatment for psoriasis and psoriatic arthritis.

Topical Ruxolitinib may safely treat severe hair loss.

Some systemic treatments work for nail psoriasis but can have serious side effects.

Acitretin effectively improved the woman's skin condition.

Various skin conditions can be treated effectively with different methods, such as discontinuing certain drugs, using specific vaccines, applying creams, and changing lifestyle habits like smoking and drinking.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

The drug combination was safe and showed promise in treating advanced tumors.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

A rare scalp condition was successfully treated with specific medications after 9 months.

Tofacitinib is an effective and safe treatment for alopecia areata.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Janus kinase inhibitors may help treat lichen planopilaris.

The combination therapy effectively improved acne keloidalis nuchae.